HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhu Wang Selected Research

Heterophile Antigens

6/2018Effect of membrane-bound complement regulatory proteins on tumor cell sensitivity to complement-dependent cytolysis triggered by heterologous expression of the α-gal xenoantigen.
6/2014CD55 limits sensitivity to complement-dependent cytolysis triggered by heterologous expression of α-gal xenoantigen in colon tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhu Wang Research Topics

Disease

54Neoplasms (Cancer)
02/2022 - 08/2006
15Breast Neoplasms (Breast Cancer)
02/2022 - 08/2012
12Prostatic Neoplasms (Prostate Cancer)
01/2022 - 06/2012
11Neoplasm Metastasis (Metastasis)
01/2022 - 07/2013
8Body Weight (Weight, Body)
01/2022 - 09/2006
7Stomach Neoplasms (Stomach Cancer)
01/2022 - 04/2015
7Inflammation (Inflammations)
11/2020 - 08/2005
6Carcinogenesis
05/2021 - 03/2010
6Hepatocellular Carcinoma (Hepatoma)
06/2019 - 08/2006
5Fibrosis (Cirrhosis)
11/2020 - 07/2015
5Type 2 Diabetes Mellitus (MODY)
05/2020 - 03/2010
5Carcinoma (Carcinomatosis)
01/2019 - 01/2010
5Acute Kidney Injury (Acute Renal Failure)
12/2016 - 10/2010
4Kidney Calculi (Kidney Stone)
08/2022 - 06/2019
4Infections
07/2022 - 08/2005
4Hemorrhage
05/2022 - 07/2015
4Abdominal Aortic Aneurysm
01/2022 - 01/2019
4Weight Gain
01/2022 - 09/2002
3Necrosis
08/2022 - 01/2013
3Mitochondrial Diseases (Mitochondrial Disease)
11/2021 - 04/2018
3Lung Neoplasms (Lung Cancer)
01/2021 - 01/2011
3Insulin Resistance
11/2020 - 05/2020
3Alzheimer Disease (Alzheimer's Disease)
01/2019 - 12/2006
3Thrombosis (Thrombus)
06/2016 - 07/2015
3Lupus Nephritis
04/2012 - 12/2010
3Proteinuria
01/2011 - 11/2007
3Sclerosis
09/2008 - 11/2007
2Pneumonia (Pneumonitis)
07/2022 - 08/2018
2Nasopharyngeal Carcinoma
01/2022 - 01/2018
2Strongyloidiasis
12/2021 - 06/2009
2Dyslipidemias (Dyslipidemia)
11/2021 - 08/2020
2Hyperlipidemias (Hyperlipidemia)
11/2021 - 09/2006
2Chronic Renal Insufficiency
10/2021 - 04/2020
2Colonic Neoplasms (Colon Cancer)
04/2021 - 06/2014
2Adenocarcinoma of Lung
01/2021 - 03/2010
2Reperfusion Injury
01/2021 - 08/2019
2Diarrhea
04/2020 - 08/2005
2Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 04/2012
2Eosinophilic Esophagitis
01/2020 - 07/2016
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 06/2014
2Atherosclerosis
11/2019 - 01/2013
2Ischemia
08/2019 - 12/2016

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
10/2021 - 05/2007
14Biomarkers (Surrogate Marker)IBA
08/2022 - 10/2010
13Messenger RNA (mRNA)IBA
01/2021 - 12/2009
9Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2022 - 04/2017
8LipidsIBA
11/2021 - 09/2006
7Blood Glucose (Blood Sugar)IBA
01/2022 - 03/2010
6Biological ProductsIBA
11/2018 - 03/2010
5Hormones (Hormone)IBA
02/2022 - 07/2009
5Pharmaceutical PreparationsIBA
12/2021 - 04/2017
5Complement System Proteins (Complement)IBA
06/2018 - 03/2010
5AntigensIBA
06/2018 - 03/2010
4TamoxifenFDA LinkGeneric
02/2022 - 12/2014
4Small Interfering RNA (siRNA)IBA
01/2022 - 10/2013
4RNA (Ribonucleic Acid)IBA
04/2021 - 10/2015
4Cisplatin (Platino)FDA LinkGeneric
01/2021 - 06/2014
4MicroRNAs (MicroRNA)IBA
01/2021 - 12/2017
4Therapeutic UsesIBA
01/2019 - 12/2010
3Triglycerides (Triacylglycerol)IBA
01/2022 - 07/2009
3Circular RNAIBA
01/2022 - 01/2017
3oxidized low density lipoproteinIBA
01/2022 - 07/2009
3Long Noncoding RNAIBA
01/2021 - 01/2018
3CarbohydratesIBA
11/2020 - 05/2015
3Glucose (Dextrose)FDA LinkGeneric
05/2020 - 03/2010
3CateninsIBA
02/2020 - 04/2012
3EnzymesIBA
01/2020 - 08/2006
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 12/2009
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2019 - 11/2007
3CarcinogensIBA
01/2019 - 01/2017
3Androgen Receptors (Androgen Receptor)IBA
11/2018 - 01/2018
3AndrogensIBA
11/2018 - 01/2018
3artemisinin (artemisinine)IBA
04/2012 - 12/2010
2LactonesIBA
08/2022 - 05/2022
2AlbuminsIBA
01/2022 - 06/2020
2Transcription Factors (Transcription Factor)IBA
01/2022 - 11/2018
2Metformin (Glucophage)FDA LinkGeneric
01/2022 - 01/2019
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2022 - 01/2021
2ArtesunateIBA
01/2021 - 01/2020
2Orphan Nuclear ReceptorsIBA
01/2021 - 01/2018
2LigandsIBA
01/2021 - 06/2009
2Alanine Transaminase (SGPT)IBA
11/2020 - 11/2014
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
11/2020 - 11/2014
2Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
11/2020 - 05/2020
2SeleniumIBA
11/2020 - 01/2011
2Calcium OxalateIBA
08/2020 - 06/2019
2Insulin (Novolin)FDA Link
05/2020 - 05/2020
2Estrogen ReceptorsIBA
02/2020 - 11/2018
2BilirubinIBA
01/2020 - 11/2014
2Peptides (Polypeptides)IBA
01/2020 - 05/2007
2Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 01/2019
2Matrix Metalloproteinases (MMPs)IBA
11/2019 - 01/2018

Therapy/Procedure

26Therapeutics
02/2022 - 04/2009
7Castration
01/2022 - 01/2018
5Drug Therapy (Chemotherapy)
01/2022 - 11/2016
4Surgical Portasystemic Shunt (Portosystemic Shunt)
06/2016 - 11/2014
4Transjugular Intrahepatic Portasystemic Shunt
06/2016 - 11/2014
3Length of Stay
05/2022 - 12/2016
2Photothermal Therapy
01/2020 - 01/2019
2Immunotherapy
01/2020 - 03/2010